Valtrex: Effective Prescription Treatment for Herpes Virus Outbreaks
| Product dosage: 1000mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.84 | $145.34 (0%) | 🛒 Add to cart |
| 60 | $4.03 | $290.68 $241.66 (17%) | 🛒 Add to cart |
| 90 | $3.76 | $436.02 $338.84 (22%) | 🛒 Add to cart |
| 120 | $3.63
Best per pill | $581.36 $435.16 (25%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.95 | $88.58 (0%) | 🛒 Add to cart |
| 60 | $2.49 | $177.16 $149.64 (16%) | 🛒 Add to cart |
| 90 | $2.33 | $265.74 $209.84 (21%) | 🛒 Add to cart |
| 120 | $2.26
Best per pill | $354.32 $271.76 (23%) | 🛒 Add to cart |
Synonyms | |||
Valtrex (valacyclovir hydrochloride) is a prescription antiviral medication specifically formulated to manage infections caused by herpes viruses, including genital herpes, cold sores, shingles, and chickenpox. As a prodrug of acyclovir, it offers enhanced bioavailability and more convenient dosing compared to earlier antiviral agents. This medication works by inhibiting viral DNA replication, thereby reducing the severity and duration of outbreaks while decreasing the likelihood of transmission to others when used as directed under medical supervision.
Features
- Active ingredient: Valacyclovir hydrochloride (converts to acyclovir in the body)
- Available in 500 mg and 1000 mg film-coated tablets
- FDA-approved for treatment and suppression of herpes simplex virus (HSV-1, HSV-2) and varicella-zoster virus (VZV)
- Demonstrated bioavailability of 54.5%, significantly higher than acyclovir
- Rapid conversion to active form following oral administration
- Suitable for episodic treatment and chronic suppressive therapy
Benefits
- Reduces healing time for herpes outbreaks by approximately 2-3 days compared to no treatment
- Decreases pain intensity and duration during acute episodes
- Lowers risk of viral transmission to partners when used as suppressive therapy
- Minimizes frequency of recurrent outbreaks with daily preventive use
- Provides convenient twice-daily or once-daily dosing depending on indication
- Helps prevent complications in immunocompromised patients
Common use
Valtrex is primarily prescribed for the management of herpes virus infections. For genital herpes, it is used both as episodic treatment (during active outbreaks) and as chronic suppressive therapy to reduce recurrence frequency. In cases of herpes labialis (cold sores), it is administered at the first sign of symptoms. For herpes zoster (shingles), treatment is initiated within 72 hours of rash appearance to accelerate healing and reduce acute pain. The medication is also used off-label for other herpesvirus infections under specialist guidance.
Dosage and direction
Dosage varies significantly based on indication and patient factors. For genital herpes treatment: 1000 mg twice daily for 10 days (initial episode) or 500 mg twice daily for 3 days (recurrent episodes). For suppression: 1000 mg once daily (or 500 mg once daily in some cases). For cold sores: 2000 mg twice daily for 1 day. For shingles: 1000 mg three times daily for 7 days. Always take with a full glass of water, with or without food. Do not crush or chew tablets. Complete the full prescribed course even if symptoms improve earlier.
Precautions
Patients should maintain adequate hydration during treatment to prevent renal complications. Those with renal impairment require dosage adjustment based on creatinine clearance. Elderly patients may need modified dosing due to age-related renal function decline. Valtrex is not a cure for herpes infections and does not prevent transmission through sexual contact; barrier protection remains necessary. Immunocompromised patients may develop thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) and require close monitoring.
Contraindications
Valtrex is contraindicated in patients with known hypersensitivity to valacyclovir, acyclovir, or any component of the formulation. It should not be administered to patients with advanced HIV disease, bone marrow transplants, or renal transplants without specialist supervision due to increased risk of thrombotic microangiopathy. The medication is contraindicated in patients with creatinine clearance below 15 mL/min without appropriate dosage adjustment.
Possible side effect
Common side effects (≥1%) include headache (13%), nausea (6%), abdominal pain (3%), vomiting (3%), and dizziness (2%). Less frequently reported are diarrhea, rash, arthralgia, and fatigue. Serious adverse effects may include neurological symptoms (agitation, hallucinations, confusion, seizures), nephrotoxicity (elevated creatinine, acute renal failure), and hematological abnormalities (thrombocytopenia, leukopenia). Any signs of thrombotic microangiopathy (fever, bruising, weakness, pallor) require immediate medical attention.
Drug interaction
Probenecid and cimetidine may decrease acyclovir clearance, increasing plasma concentrations. Drugs that affect renal function (NSAIDs, aminoglycosides, cyclosporine) may increase nephrotoxic potential. Concurrent use with other nephrotoxic agents requires careful monitoring. No significant interactions with oral contraceptives have been documented. Limited data exists regarding interactions with highly protein-bound drugs, though theoretical displacement interactions are considered unlikely.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing intervals to ensure consistent antiviral activity. For twice-daily regimens, if remembered within 6 hours of missed dose, take immediately; if beyond 6 hours, skip and resume normal schedule. For once-daily dosing, take within 12 hours of missed dose or skip if beyond.
Overdose
Overdose may manifest as neurological symptoms including agitation, hallucinations, confusion, and seizures. Renal impairment may occur with excessive doses. Management includes supportive care and hemodialysis, which significantly enhances acyclovir clearance (approximately 60% removal during 4-hour session). Maintain adequate hydration and monitor renal function. There is no specific antidote; treatment remains symptomatic and supportive.
Storage
Store at room temperature (20-25°C or 68-77°F) in original container. Protect from moisture and light. Keep tightly closed and out of reach of children. Do not store in bathroom or other humid areas. Discard any medication that has expired or shows signs of deterioration (discoloration, unusual odor). Do not flush medications; dispose of properly through take-back programs.
Disclaimer
This information does not replace professional medical advice. Valtrex is available by prescription only and should be used under appropriate medical supervision. Individual response to treatment may vary. Consult a healthcare provider for proper diagnosis, dosage recommendations, and monitoring. Report any adverse effects to your physician immediately. The full prescribing information contains complete details regarding usage, warnings, and precautions.
Reviews
Clinical studies demonstrate Valtrex’s efficacy across multiple indications. In genital herpes suppression trials, 69% of patients remained recurrence-free during 6 months of therapy versus 9.5% with placebo. For shingles treatment, Valtrex reduced pain duration by 25% compared to placebo. Patient-reported outcomes indicate improved quality of life measures and satisfaction with convenience of dosing. Real-world evidence supports its favorable benefit-risk profile when used appropriately in indicated populations.